ТРАУМАТОЛОГИЈА И УРГЕНТНА МЕДИЦИНА
Лечење и контрола хемостазе
српски (ћирилица)
Лечење и контрола хемостазе
/assets/ct/28ada02fb0/images/syn_placeholder_sqr.png

Трауматологија и ургентна медицина

Лечење и контрола хемостазе

Антифибринолитичке супстанције

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (отвара нови прозор)

Coccolini F, Shander A, Ceresoli M, Moore E, Tian B, Parini D, Sartelli M, Sakakushev B, Doklestich K, Abu-Zidan F, Horer T, Shelat V, Hardcastle T, Bignami E, Kirkpatrick A, Weber D, Kryvoruchko I, Leppaniemi A, Tan E, Kessel B, Isik A, Cremonini C, Forfori F, Ghiadoni L, Chiarugi M, Ball C, Ottolino P, Hecker A, Mariani D, Melai E, Malbrain M, Agostini V, Podda M, Picetti E, Kluger Y, Rizoli S, Litvin A, Maier R, Beka SG, De Simone B, Bala M, Perez AM, Ordonez C, Bodnaruk Z, Cui Y, Calatayud AP, de Angelis N, Amico F, Pikoulis E, Damaskos D, Coimbra R, Chirica M, Biffl WL, Catena F

Извор‎: World J Emerg Surg 2024;19(1):26.

Alternatives to allogeneic platelet transfusion. (отвара нови прозор)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Извор‎: Br J Haematol 2016;175(3):381-92.

Antifibrinolytic drugs for acute traumatic injury. (отвара нови прозор)

Ker K, Roberts I, Shakur H, Coats TJ.

Извор‎: Cochrane Database Syst Rev 2015;(5):CD004896.

Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. (отвара нови прозор)

Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE.

Извор‎: JAMA Surg 2013;148(3):218-25.

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (отвара нови прозор)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Извор‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Рекомбиновани активирани фактор VII (rFVIIa)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (отвара нови прозор)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Извор‎: Transfusion 2009;49 Suppl 5:240S-7S.

Концентрати фактора коагулације

The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. (отвара нови прозор)

Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M.

Извор‎: Injury 2013;44(2):209-16.

Дезмопресин

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (отвара нови прозор)

Coccolini F, Shander A, Ceresoli M, Moore E, Tian B, Parini D, Sartelli M, Sakakushev B, Doklestich K, Abu-Zidan F, Horer T, Shelat V, Hardcastle T, Bignami E, Kirkpatrick A, Weber D, Kryvoruchko I, Leppaniemi A, Tan E, Kessel B, Isik A, Cremonini C, Forfori F, Ghiadoni L, Chiarugi M, Ball C, Ottolino P, Hecker A, Mariani D, Melai E, Malbrain M, Agostini V, Podda M, Picetti E, Kluger Y, Rizoli S, Litvin A, Maier R, Beka SG, De Simone B, Bala M, Perez AM, Ordonez C, Bodnaruk Z, Cui Y, Calatayud AP, de Angelis N, Amico F, Pikoulis E, Damaskos D, Coimbra R, Chirica M, Biffl WL, Catena F

Извор‎: World J Emerg Surg 2024;19(1):26.

Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury. (отвара нови прозор)

Furay EJ, Daley MJ, Satarasinghe P, Lara S, Aydelotte JD, Teixeira PG, Coopwood TB, Ali S, Brown CVR

Извор‎: J Trauma Acute Care Surg 2020;88(1):80-6.

Вискоеластични тестови за идентификацију крварења током операције или код коагулопатије

Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. (отвара нови прозор)

Brenni M, Worn M, Brüesch M, Spahn DR, Ganter MT.

Извор‎: Acta Anaesthesiol Scand 2010;54(1):111-7.